Menu Close

Why Target-Date Funds Might Not Be the Best Retirement Planning Option for You

Associated Press

Pfizer asks EU drug regulator to OK tweaked COVID vaccine

Pfizer and BioNTech have asked the European Medicines Agency to authorize their updated coronavirus booster vaccine that includes the most recent omicron subvariants. In a statement Friday, Pfizer said it is requesting that the EU drug regulator OK its combination COVID-19 vaccine that targets the original coronavirus and BA.4 and BA.5, the latest versions of omicron, which are causing the vast majority of infections globally now. Pfizer and BioNTech are asking that the vaccine be given the green light for people aged 12 and over.